{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:37:07Z","timestamp":1790674627370,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, & Immunity - Health"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.bbih.2022.100482","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T12:41:42Z","timestamp":1655988102000},"page":"100482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Behavioral- and blood-based biomarkers for Huntington's disease: Studies on the R6\/1 mouse model with prospects for early diagnosis and monitoring of the disease"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7709-5955","authenticated-orcid":false,"given":"Magdalena","family":"Podlacha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Pierzynowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Gaffke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u017cyna","family":"Jerzemowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Piotrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"W\u0119grzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbih.2022.100482_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.coph.2015.09.008","article-title":"Disruption of immune cell function by mutant huntingtin in Huntington's disease pathogenesis","volume":"26","author":"Andre","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bbih.2022.100482_bib2","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/jc.2008-2543","article-title":"Increased hypothalamic-pituitary-adrenal axis activity in huntington's disease","volume":"94","author":"Aziz","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbih.2022.100482_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2021.109281","article-title":"The blood biomarkers puzzle \u2013 a review of protein biomarkers in neurodegenerative diseases","volume":"361","author":"Barro","year":"2021","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbih.2022.100482_bib4","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbih.2022.100482_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacl.2009.11.003","article-title":"Altered cholesterol and fatty acid metabolism in Huntington disease","volume":"4","author":"Block","year":"2010","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.bbih.2022.100482_bib6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jad.2018.11.018","article-title":"Inflammatory cytokines and cognitive functioning in early-stage bipolar I disorder","volume":"245","author":"Chakrabarty","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbih.2022.100482_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","article-title":"Plasma inflammatory biomarkers for Huntington's disease patients and mouse model","volume":"44","author":"Chang","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbih.2022.100482_bib8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.14336\/AD.2019.0118","article-title":"Emerging roles of complement protein C1q in neurodegeneration","volume":"10","author":"Cho","year":"2019","journal-title":"Aging Dis"},{"key":"10.1016\/j.bbih.2022.100482_bib9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1021\/acschemneuro.6b00042","article-title":"The immune system and neuroinflammation as potential sources of blood-based biomarkers for alzheimers disease, Parkinsons disease, and huntingtons disease","volume":"7","author":"Clark","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbih.2022.100482_bib10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington's disease","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbih.2022.100482_bib11","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbih.2022.100482_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbr.2006.12.004","article-title":"Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease","volume":"178","author":"Dorner","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbih.2022.100482_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bbi.2020.06.007","article-title":"Exploratory study of association between blood immune markers and cognitive symptom severity in major depressive disorder: stratification by body mass index status","volume":"88","author":"Fourrier","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbih.2022.100482_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbih.2022.100482_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0203559","article-title":"Impact of repeated anesthesia with ketamine and xylazine on the well-being of C57BL\/6JRj mice","volume":"13","author":"Hohlbaum","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bbih.2022.100482_bib16","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/14737175.2020.1801424","article-title":"Gene therapy and immunotherapy as promising strategies to combat Huntington's disease-associated neurodegeneration: emphasis on recent updates and future perspectives","volume":"20","author":"Jamwal","year":"2020","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbih.2022.100482_bib17","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s11011-018-0308-1","article-title":"Mitochondrial alterations accompanied by oxidative stress conditions in skin fibroblasts of Huntington's disease patients","volume":"33","author":"J\u0119drak","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbih.2022.100482_bib18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jad.2020.08.024","article-title":"Linking peripheral IL-6, IL-1\u03b2 and hypocretin-1 with cognitive impairment from major depression","volume":"277","author":"Jin","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbih.2022.100482_bib19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3233\/JHD-170279","article-title":"Cognitive dysfunction contributes to mobility impairments in huntington's disease","volume":"6","author":"Kloos","year":"2017","journal-title":"J. Huntingtons. Dis."},{"key":"10.1016\/j.bbih.2022.100482_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cyto.2019.02.001","article-title":"The role of cytokines in the regulation of NK cells in the tumor environment","volume":"117","author":"Konjevi\u0107","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.bbih.2022.100482_bib21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archneur.65.4.476","article-title":"Glucose homeostasis in huntington disease","volume":"65","author":"Lali\u0107","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbih.2022.100482_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02405","article-title":"Expression of human mutant huntingtin protein in Drosophila hemocytes impairs immune responses","volume":"10","author":"Lin","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbih.2022.100482_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01349-z","article-title":"Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease","volume":"11","author":"Lyra e Silva","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbih.2022.100482_bib24","article-title":"Stress and glucocorticoids as experience-dependent modulators of huntington's disease","volume":"3","author":"Mo","year":"2019","journal-title":"Stress: Physiol. Biochem. Pathol. Handbook Stress Series"},{"key":"10.1016\/j.bbih.2022.100482_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JHD-170253","article-title":"Huntington's disease and diabetes: chronological sequence of its association","volume":"6","author":"Montojo","year":"2017","journal-title":"J. Huntingtons. Dis."},{"key":"10.1016\/j.bbih.2022.100482_bib26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.neuroscience.2003.08.053","article-title":"Molecular and behavioral analysis of the R6\/1 Huntington's disease transgenic mouse","volume":"122","author":"Naver","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbih.2022.100482_bib27","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nbd.2007.11.006","article-title":"Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice","volume":"29","author":"Nithianantharajah","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbih.2022.100482_bib28","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbih.2022.100482_bib29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.neuropharm.2019.01.030","article-title":"Autophagy-dependent mechanism of genistein-mediated elimination of behavioral and biochemical defects in the rat model of sporadic Alzheimer's disease","volume":"148","author":"Pierzynowska","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbih.2022.100482_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145133","article-title":"Hair dysmorphology in the R6\/1 and R6\/2 mouse models of Huntington's disease","volume":"765","author":"Pierzynowska","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.bbih.2022.100482_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11481-015-9632-y","article-title":"Medial septal NMDA glutamate receptors are involved in modulation of blood natural killer cell activity in rats","volume":"11","author":"Podlacha","year":"2016","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bbih.2022.100482_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2015.08.011","article-title":"Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers","volume":"83","author":"Politis","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbih.2022.100482_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22041561","article-title":"What, when and how to measure\u2014peripheral biomarkers in therapy of huntington's disease","volume":"22","author":"Przybyl","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbih.2022.100482_bib34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.psyneuen.2011.09.009","article-title":"Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions","volume":"37","author":"Russell","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbih.2022.100482_bib35","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1179\/1743132812Y.0000000073","article-title":"Oxidative stress and inflammation biomarkers in the blood of patients with huntington's disease","volume":"34","author":"S\u00e1nchez-L\u00f3pez","year":"2012","journal-title":"Neurol. Res."},{"key":"10.1016\/j.bbih.2022.100482_bib36","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.bbih.2022.100482_bib37","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.psyneuen.2012.10.020","article-title":"Cortisol and depression in pre-diagnosed and early stage Huntington's disease","volume":"38","author":"Shirbin","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbih.2022.100482_bib38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JHD-170273","article-title":"A critical evaluation of wet biomarkers for huntington's disease: current status and ways forward","volume":"7","author":"Silajdzic","year":"2018","journal-title":"J. Huntingtons. Dis."},{"key":"10.1016\/j.bbih.2022.100482_bib39","article-title":"2021. Deciphering the key mechanisms leading to alteration of lipid metabolism in Drosophila model of Huntington's disease","author":"Singh","year":"1867","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.bbih.2022.100482_bib40","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2018.09.022","article-title":"Huntington disease: a quarter century of progress since the gene discovery","volume":"396","author":"Testa","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbih.2022.100482_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116653","article-title":"Inflammatory changes in peripheral organs in the BACHD murine model of Huntington's disease","volume":"232","author":"Valad\u00e3o","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.bbih.2022.100482_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577380","article-title":"Inflammation in Huntington's disease: a few new twists on an old tale","volume":"348","author":"Valad\u00e3o","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbih.2022.100482_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2014.00231","article-title":"Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients","volume":"5","author":"Wang","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbih.2022.100482_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-00379-3","article-title":"Interleukin-6 deficiency exacerbates Huntington's disease model phenotypes","volume":"15","author":"Wertz","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbih.2022.100482_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.131","article-title":"N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6\/1 mouse model of Huntington's disease","volume":"5","author":"Wright","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbih.2022.100482_bib46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.parkreldis.2012.09.012","article-title":"The influence of gender on phenotype and disease progression in patients with Huntington's disease","volume":"19","author":"Zielonka","year":"2013","journal-title":"Park. Relat. Disord."}],"container-title":["Brain, Behavior, & Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354622000722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354622000722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:25:35Z","timestamp":1762986335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666354622000722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":46,"alternative-id":["S2666354622000722"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2022.100482","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioral- and blood-based biomarkers for Huntington's disease: Studies on the R6\/1 mouse model with prospects for early diagnosis and monitoring of the disease","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2022.100482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100482"}}